Evidence map›Paper›PMID 41826645›Full record

ArticleExperimental & molecular medicine2026

TANK-binding kinase 1 protects against MASH progression via mitochondrial quality control.

Sung-Min An, Jun Hee Jang, Jin Hyun Sung, Ji Won Myung, Yong Geun Jeon, Won Taek Lee, Jin Won Jeon, Kyung Min Yim, Jae-Ho Lee, Bichen Zhang and 5 more

Abstract read
In one paragraph

Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cell Type-Specific Roles of TBK1 in Steatotic Liver Disease: Evidence for an Inflammatory TBK1Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Sung-Min An *Center for Nano Materials, Department of Life Science, Sogang University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0003-2122-4452
Jun Hee Jang *Center for Nano Materials, Department of Life Science, Sogang University, Seoul, Republic of Korea.
Jin Hyun SungCenter for Nano Materials, Department of Life Science, Sogang University, Seoul, Republic of Korea.
Ji Won MyungCenter for Nano Materials, Department of Life Science, Sogang University, Seoul, Republic of Korea.
Yong Geun JeonNational Leading Researcher Initiatives Center for Adipocyte Structure and Function, Institute of Molecular Biology and Genetics, School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-1422-9151
Won Taek LeeNational Leading Researcher Initiatives Center for Adipocyte Structure and Function, Institute of Molecular Biology and Genetics, School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
Jin Won JeonCenter for Nano Materials, Department of Life Science, Sogang University, Seoul, Republic of Korea.
Kyung Min YimNational Leading Researcher Initiatives Center for Adipocyte Structure and Function, Institute of Molecular Biology and Genetics, School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
Jae-Ho LeeDepartment of Physiology, College of Medicine and Institute of Medical Sciences, Gyeongsang National University, Jinju, Republic of Korea.
Bichen ZhangDepartment of Medicine, University of California, San Diego, San Diego, CA, USA.
Jong Bae SeoDepartment of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Jeonnam, Republic of Korea.ORCID http://orcid.org/0000-0001-5058-5156
Seung Soon ImDepartment of Physiology, Keimyung University School of Medicine, Daegu, Republic of Korea.
Jae Bum KimNational Leading Researcher Initiatives Center for Adipocyte Structure and Function, Institute of Molecular Biology and Genetics, School of Biological Sciences, Seoul National University, Seoul, Republic of Korea. jaebkim@snu.ac.kr.ORCID http://orcid.org/0000-0003-2337-6935
Alan R SaltielDepartment of Medicine, University of California, San Diego, San Diego, CA, USA. asaltiel@health.ucsd.edu.ORCID http://orcid.org/0000-0002-9726-9828
Jin Young HuhCenter for Nano Materials, Department of Life Science, Sogang University, Seoul, Republic of Korea. jyhuh@sogang.ac.kr.ORCID http://orcid.org/0000-0002-0980-7199

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALAN R. SALTIEL · 2003 to 2026
$40.4M
American Heart Association (American Heart Association, Inc.) 24POST1187840National Research Foundation of Korea (NRF) 2020R1A3B2078617, RS-2023-00218616National Research Foundation of Korea (NRF) 2021R1C1C2010446, RS-2025-24803090, RS-2024-00441954NIDDK NIH HHS P30 DK063491U.S. Department of Health & Human Services | National Institutes of Health (NIH) RO1 DK124496, RO1 DK117551
6 · The paper itself

Abstract

Mitochondrial dysfunction is a critical driver of metabolic dysfunction-associated steatotic liver disease progression to steatohepatitis (MASH), yet the mechanisms governing mitochondrial quality control in hepatocytes remain poorly defined. Here we identify TANK-binding kinase 1 (TBK1) as an essential regulator of hepatic mitophagy and lysosomal activity. Using TBK1-deficient hepatocytes and liver-specific TBK1-knockout mice, we show that TBK1 loss leads to the accumulation of depolarized, reactive oxygen species-producing mitochondria due to impaired mitophagy flux, including defective lysosomal degradation. Mechanistically, TBK1 is required for p62 phosphorylation at Ser403 and partially modulates mTOR signaling to preserve lysosomal activity. Notably, both human samples and murine steatohepatitis models exhibited a substantial decline in TBK1 kinase activity. Therapeutic restoration of TBK1 expression via AAV8 delivery in MASH mouse model enhanced mitophagy, reduced mitochondrial burden and ameliorated liver fibrosis. Collectively, these findings establish TBK1 as a critical guardian of mitochondrial and lysosomal homeostasis in MASH.

Indexed as

Fatty LiverMitochondriaProtein Serine-Threonine KinasesAnimalsDisease Models, AnimalDisease ProgressionHepatocytesHumansLysosomesMiceMice, KnockoutMitophagyReactive Oxygen SpeciesSignal TransductionProtein Serine-Threonine KinasesReactive Oxygen SpeciesTBK1 protein, humanTbk1 protein, mouse

Identifiers

PMID41826645
PMCPMC13049026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.